Laboratoires Thea

This study tested two new strengths of an experimental eye drop called T4090 against an already approved drop, Rhopressa. The goal was to see if the new drops are as good or better at safely lowering high pressure inside the eye for people with glaucoma. About 161 adults with ope…

This study compared a new eye drop called T2769 to an existing treatment (Vismed Multi) for people with moderate to severe dry eye. It involved 251 adults who needed artificial tears for at least three months. The main goal was to see if T2769 was at least as good as the existing…

This study compared a new eye drop called T2769 to an existing one called Hylo-Forte® for treating moderate to severe dry eye. It involved 74 adults whose dry eye symptoms persisted despite using artificial tears. The main goal was to see if T2769 was at least as good as Hylo-For…

This study tested a new type of preservative-free eye drops in 30 adults with long-term, moderate-to-severe dry eye disease. The goal was to see if the drops could reduce eye redness and improve patients' feelings of comfort and relief over 12 weeks of daily use. It focused on me…